Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
AQST
#2916
Aquestive Therapeutics, Inc. Common Stock
4.1
5
USD
-0.95%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-0.95%
Changement Mensuel
+2.98%
Evolution sur 6 mois
-40.37%
Changement Annuel
+64.68%
Clôture Précédente
4.1
9
Open
4.1
5
Bid
Ask
Low
4.1
5
High
4.1
5
Volume
79
Marchés
Actions des Marchés US
Soins de Santé
AQST
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
36.21 M
41.47 M
55.87 M
73.3 M
98.87 M
122.05 M
—
Valuation ratios
Enterprise value
217.01 M
215.65 M
107.12 M
198.14 M
402.46 M
838.38 M
2.03 B
Price to earnings ratio
—
-2.1
-0.8
-15.46
-6.98
-8.28
-26.06
Price to sales ratio
—
2.91
0.92
2.43
5.36
15.51
39.86
Price to cash flow ratio
—
-4.49
-4.48
-19.3
-8.63
-13.17
-35.8
Price to book ratio
—
-1.8
-0.37
-1.16
-5.13
-20.52
-25.78
Enterprise value to EBITDA ratio
-3.98
-5.76
-1.27
5.04
-13.77
-11.98
35.27
Profitability ratios
Return on assets %
-0.89
-1.14
-0.95
-0.14
-0.44
-0.52
-0.66
Return on equity %
1.15
0.86
0.46
0.07
0.73
2.49
5.27
Return on invested capital %
-977.37
—
—
—
—
—
—
Gross margin %
71.72
100
100
58.82
68.95
58.35
232.5
Operating margin %
-93.55
-68.22
-88.23
-29.86
-53.46
-159.5
-646.94
EBITDA margin %
-88.7
-55.05
-82.77
57.79
-44.39
-147.76
211.58
Net margin %
-121.67
-138.77
-114.11
-15.56
-76.68
-188.09
-763.8
Liquidity ratios
Quick ratio
2
1.97
0.86
1.87
4.36
3.01
16.29
Current ratio
2.11
2.15
1.01
2.24
4.68
3.14
17.47
Inventory turnover
4.87
—
—
3.32
2.79
3.04
2.54
Asset turnover
0.65
0.81
0.8
0.88
0.72
0.34
0.37
Solvency ratios
Debt to assets ratio
0.88
0.88
1
0.88
0.5
0.31
1.65
Debt to equity ratio
-1.14
-0.66
-0.48
-0.48
-0.84
-1.48
-15.2
Long term debt to total assets ratio
0.82
0.83
0.9
0.78
0.44
0.28
1.48
Long term debt to total equity ratio
-1.06
-0.63
-0.43
-0.42
-0.75
-1.34
-13.65
Per share metrics
Operating cash flow per share
—
-0.87
-0.2
-0.1
-0.41
-0.49
-0.52
EBIT per share
—
-0.91
-0.86
-0.25
-0.35
-0.66
-0.69
EBITDA per share
—
-0.73
-0.81
0.48
-0.29
-0.62
0.23
Total debt per share
—
1.43
1.17
0.83
0.58
0.47
1.95
Cash per share
—
—
—
—
—
—
—
Net current asset value per share
—
1.24
0.82
0.67
1.02
1.4
4.52
Tangible book value per share
—
-2.16
-2.46
-1.76
-0.69
-0.31
-1.72
Working capital per share
—
0.66
0.01
0.37
0.8
0.95
3.42
Book value per share
—
-2.16
-2.43
-1.74
-0.69
-0.31
-1.72
Nouvelles
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Aquestive réaffirme le dépôt de sa NDA pour Anaphylm au T3 2026
Aquestive nomme Thomas Zalewski directeur juridique
Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST)
Le directeur des ressources humaines d’Aquestive Therapeutics vend pour 124.000$ d’actions
Aquestive Therapeutics chief people officer Boyd sells $124k in stock
Le PDG d’Aquestive Therapeutics Barber vend pour 753.965$ d’actions
La vice-présidente d’Aquestive Therapeutics Cioffi vend pour 105.000$ d’actions
La directrice juridique d’Aquestive Therapeutics, Braender, vend pour 167.000$ d’actions
Aquestive Therapeutics CEO Barber sells $753,965 in stock
Aquestive Therapeutics SVP Cioffi sells $105k in shares
Aquestive therapeutics chief legal officer Braender sells $167k in stock